OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Excerpts from this story referencing "Obama":

"… s year if that’s even remotely possible.   …"

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Excerpts from this story referencing "Supreme Court":

"… is report. …"

Federal regulators have failed to act on toxic chemical, report says

By Chris Hamby

Regulators have done little to protect the public from BPA, critics say

Excerpts from this story referencing "Health":

"… bels and ban certain uses of the chemical. And the Occupational Safety and Health Administration could set and enforce limits on how much BPA workers can br …"

Report faults Medicare controls on widely abused drugs

By Joe Eaton

Beneficiaries easily went to multiple doctors for hydrocodone and oxycodone

Excerpts from this story referencing "Tom Carper":

"… reed that a restricted recipient program was necessarily the solution.Sen. Tom Carper, D-Del., one of those who requested the GAO inquiry, said the abuse of dru …"

Inspectors struggle to keep up with flood of imports

By Brad Racino

Food imports approved for use in the U.S. in an unexpected way

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

FDA's flimsy recall power for food imports puts public at risk, watchdog says

By Aaron Mehta and Ben Wieder

FDA needs more power to police recalls of imported foods

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

Excerpts from this story referencing "China":

"… iginate in developing countries. The top seafood exporters to the U.S. are China, Thailand, Canada, Indonesia, Vietnam and Ecuador. …"

During Mitch Daniels’ decade at Eli Lilly, the drug giant paid billions in fines and settled thousands of lawsuits

By Joanne Kenen and Rochelle Sharpe

Eli Lilly paid billions in fines, settled thousands of lawsuits while Daniels was an executive at the drug giant

Excerpts from this story referencing "Mitch Daniels":

"… Laurel Adams and Aaron Mehta contributed to this story.  …"

"… ntal in the Zyprexa settlement. “Bill Clinton had the bimbo factor. Mitch Daniels is going to need a strategy to counteract the assumption that will be made …"

"… ossible that he wouldn’t have known a thing,” Loss said, but added, “Mitch Daniels can’t walk into the presidential race and not expect questions about thi …"

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Excerpts from this story referencing "Portland":

"… . First, two of the doctors were dead. A third doctor was alive, living in Portland, Ore., but he never wrote the prescriptions. The fourth doctor was a few m …"

"… these numbers,” Hoven told the Center in an e-mail.But Luis Scheker, the Portland dermatologist whose identity was used by Rodriguez’s phony Miami pharmac …"

"… . Scheker said he is unsure how his number was stolen.Soon after moving to Portland in 2009, Scheker said he contacted insurance companies because he was rece …"

FDA criticized for accepting free help from company that later won generic OK

By Laurel Adams

The Food and Drug Administration last month issued guidelines for agency staff to follow when drugmakers offer free help during emergencies

Excerpts from this story referencing "The Wall Street Journal":

"… ll a generic version of the fast-acting bloodthinner Lovenox, according to The Wall Street Journal. The FDA says Momenta’s free work did not influence the agency’s decis …"

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Excerpts from this story referencing "research":

"… cording to a new report from the National Academy of Sciences.In the past, researchers concerned with how a study might damage a fetus or how the flux of horm …"

"… ed getting attention in 1985, and touched off a shift toward more accurate research and regulation.Clinical trials about diseases, devices and drugs don’t r …"

"… cts on men and women before going on the market. The study also encouraged researches to take quality of life concerns, which women often rank as more importa …"

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

Excerpts from this story referencing "Health":

"… blic comment.”Gasparoli noted that the FDA’s parent, the Department of Health and Human Services, has already posted on www.data.gov the Electronic Anim …"

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

FDA enforcement actions way down

By The Center for Public Integrity

Enforcement actions by the (FDA) markedly declined under the Bush administration

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

Excerpts from this story referencing "pain":

"… most glaring failure: its lack of action against the popular arthritis and pain medication Vioxx despite clear and convincing evidence that the drug posed …"

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Excerpts from this story referencing "Government Accountability Office":

"… oss. A September 2002 study by the U.S. General Accounting Office (now the Government Accountability Office) stated that "the median approval time for new drug applications for stand …"

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

Excerpts from this story referencing "Medicare":

"… kers that drew heavy drug industry lobbying was to undo a provision of the Medicare Prescription Drug, Improvement and Modernization Act of 2003. The legislat …"

"… g blitz, guarantees that the nation's seniors and the disabled who receive Medicare are eligible for some form of prescription drug benefit starting in Januar …"

"… he federal government from negotiating on prices of drugs supplied through Medicare. Many other bulk purchasers, including private insurers and federal depart …"

"… e Secretary of Health and Human Services to negotiate for lower prices for Medicare prescription drugs. A spokeswoman for Wu said the bill never made it out o …"

PEPFAR policy hinders treatment in generic terms

By M. Asif Ismail

Critics say FDA approval rule has meant greater use of high-cost drugs at expense of helping fewer patients

Drug makers' dime funds Congressional travel

By Robert Brodsky

Pharmaceutical companies, affiliated trade groups spent more than $600,000 on trips

Excerpts from this story referencing "John Breaux":

"… t reliable allies of the pharmaceutical industry in Congress was then-Sen. John Breaux of Louisiana. During his nearly two decades in the Senate, Breaux develope …"

Deep pockets contribute to success

By M. Asif Ismail

Industry spends millions on state campaign donations, Calif. fight

Excerpts from this story referencing "Arnold Schwarzenegger":

"… least $570,000. More than $100,000 apiece also was given to his successor Arnold Schwarzenegger and fellow Republicans Gov. Rick Perry of Texas and Mark Earley, the party …"

States see importation as solution to high drug costs

By Victoria Kreha

Several seek, have plans despite federal and industry opposition

Excerpts from this story referencing "Pennsylvania":

"… "without taking a trip across the border." Several other states, including Pennsylvania, Minnesota, Virginia and Tennessee, also have introduced bills proposing t …"

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

Excerpts from this story referencing "FDA's":

"… 00 drugs on the market.The Center for Public Integrity analyzed all of the FDA's available reports of privately sponsored trips taken by agency officials b …"

"… aceutical-related companies.Charles Hoiberg, former deputy director of the FDA's Office of New Drug Chemistry, now works for Pfizer. Hoiberg is a board mem …"

"… imbursement to the FDA staffer.Ajaz Hussain, former deputy director of the FDA's Office of Pharmaceutical Science, took more than 35 privately sponsored tr …"

"… ilize the resources you have," Hussain said, citing the limitations in the FDA's travel budget as a reason for accepting outside sponsored travel. "You hav …"

Drug lobby second to none

By M. Asif Ismail

How the pharmaceutical industry gets its way in Washington

Surrogates for their agenda

By Alexander Cohen

How the drug industry uses non-profits to push its interests

Excerpts from this story referencing "television advertising":

"… The United Seniors Association spent more than $18.5 million on radio and television advertising in 2002 and more than $23 million in 2003, much of it supporting Republica …"

Checkbook politics

By Victoria Kreha

Over the last seven years, the pharmaceutical industry has given $150 million in campaign contributions